Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration

References

• Ader P, Wessmann A, Wolffram S. (2000). Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 28:1056–1067.
   PubMed Web of Science ®Google Scholar
• Bock KW, Bock-Hennig BS. (2010). UDP-glucuronosyltransferases (UGTs): from purification of Ah-receptor-inducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptors. Drug Metab Rev 42:6–13.
   PubMed Web of Science ®Google Scholar
• Boots AW, Haenen GR, Bast A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325–337.
   PubMed Web of Science ®Google Scholar
• Brouard C, Siess MH, Vernevaut MF, Suschetet M. (1988). Comparison of the effects of feeding quercetin or flavone on hepatic and intestinal drug-metabolizing enzymes of the rat. Food Chem Toxicol 26:99–103.
   PubMed Web of Science ®Google Scholar
• Canivenc-Lavier MC, Vernevaut MF, Totis M, Siess MH, Magdalou J, Suschetet M. (1996). Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology 114:19–27.
   PubMed Web of Science ®Google Scholar
• Cermak R, Landgraf S, Wolffram S. (2003). The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J Nutr 133:2802–2807.
   PubMed Web of Science ®Google Scholar
• Cermak R, Wein S, Wolffram S, Langguth P. (2009). Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs. Eur J Pharm Sci 38:519–524.
   PubMed Web of Science ®Google Scholar
• Critchfield JW, Welsh CJ, Phang JM, Yeh GC. (1994). Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 48:1437–1445.
   PubMed Web of Science ®Google Scholar
• Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ. (2008). Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138:1615–1621.
   PubMed Web of Science ®Google Scholar
• Galijatovic A, Walle UK, Walle T. (2000). Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells. Pharm Res 17:21–26.
   PubMed Web of Science ®Google Scholar
• Graefe EU, Derendorf H, Veit M. (1999). Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int J Clin Pharmacol Ther 37:219–233.
   PubMed Web of Science ®Google Scholar
• Harborne JB, Williams CA. (2000). Advances in flavonoid research since 1992. Phytochemistry 55:481–504.
   PubMed Web of Science ®Google Scholar
• Hertog MGL, Hollman PCH, Katan MB, Kromhout D. (1993). Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer, 20, 21–29.
   PubMed Web of Science ®Google Scholar
• James MO, Sacco JC, Faux LR. (2008). Effects of Food Natural Products on the Biotransformation of PCBs. Environ Toxicol Pharmacol 25:211–217.
   PubMed Web of Science ®Google Scholar
• Lesser S, Cermak R, Wolffram S. (2004). Bioavailability of quercetin in pigs is influenced by the dietary fat content. J Nutr 134:1508–1511.
   PubMed Web of Science ®Google Scholar
• Levy G, Matsuzawa T. (1967). Pharmacokinetics of salicylamide elimination in man. J Pharmacol Exp Ther 156:285–293.
   PubMed Web of Science ®Google Scholar
• Levy G, Procknal JA. (1968). Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man. J Pharm Sci 57:1330–1335.
   PubMed Web of Science ®Google Scholar
• Manach C, Morand C, Demigné C, Texier O, Régérat F, Rémésy C. (1997). Bioavailability of rutin and quercetin in rats. FEBS Lett 409:12–16.
   PubMed Web of Science ®Google Scholar
• Middleton E Jr, Kandaswami C, Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751.
   PubMed Web of Science ®Google Scholar
• Morand C, Crespy V, Manach C, Besson C, Demigné C, Rémésy C. (1998). Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275:R212–R219.
   PubMed Web of Science ®Google Scholar
• Morris ME, Levy G. (1983). Determination of salicylamide and five metabolites in biological fluids by high-performance liquid chromatography. J Pharm Sci 72:612–617.
   PubMed Web of Science ®Google Scholar
• Morris ME, Zhang S. (2006). Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 78:2116–2130.
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Breinholt V, Justesen U, Cornett C, Dragsted LO. (1998). In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28:389–401.
   PubMed Web of Science ®Google Scholar
• Nishimuta H, Ohtani H, Tsujimoto M, Ogura K, Hiratsuka A, Sawada Y. (2007). Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. Biopharm Drug Dispos 28:491–500.
   PubMed Web of Science ®Google Scholar
• Odbayar TO, Kimura T, Tsushida T, Ide T. (2009). Isoenzyme-specific up-regulation of glutathione transferase and aldo-keto reductase mRNA expression by dietary quercetin in rat liver. Mol Cell Biochem 325:121–130.
   Google Scholar
• Rafferty AP, McGee HB, Miller CE, Reyes M. (2002). Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 92:1598–1600.
   PubMed Web of Science ®Google Scholar
• Siess MH, Guillermic M, Le Bon AM, Suschetet M. (1989). Induction of monooxygenase and transferase activities in rat by dietary administration of flavonoids. Xenobiotica 19:1379–1386.
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. (2000). Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616.
   PubMed Web of Science ®Google Scholar
• Van der Heiden E, Bechoux N, Muller M, Sergent T, Schneider YJ, Larondelle Y, Maghuin-Rogister G, Scippo ML. (2009). Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Anal Chim Acta 637:337–345.
   PubMed Web of Science ®Google Scholar
• van der Logt EM, Roelofs HM, Nagengast FM, Peters WH. (2003). Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24:1651–1656.
   PubMed Web of Science ®Google Scholar
• Walle UK, Walle T. (2002). Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. Drug Metab Dispos 30:564–569.
   PubMed Web of Science ®Google Scholar
• Zhu BT, Taneja N, Loder DP, Balentine DA, Conney AH. (1998). Effects of tea polyphenols and flavonoids on liver microsomal glucuronidation of estradiol and estrone. J Steroid Biochem Mol Biol 64:207–215.
   PubMed Web of Science ®Google Scholar